What is the treatment for acute pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Pericarditis

First-line treatment for acute pericarditis consists of NSAIDs/Aspirin plus colchicine, with therapy continued until both symptoms resolve and CRP normalizes. 1

Initial Assessment and Risk Stratification

Acute pericarditis should be diagnosed when at least 2 of 4 criteria are present:

  • Characteristic pleuritic chest pain
  • Pericardial friction rub
  • ECG changes (widespread ST elevation, PR depression)
  • New or worsening pericardial effusion 1

Risk stratification is essential to determine management:

  • High-risk features requiring hospitalization:
    • Fever >38°C (100.4°F)
    • Subacute onset
    • Large pericardial effusion (>20mm)
    • Cardiac tamponade
    • Failure to respond to NSAIDs within 7 days 2
    • Immunosuppression, trauma, or anticoagulant therapy 2
  • Low-risk patients without these features can be managed as outpatients 2

First-Line Treatment

1. NSAIDs/Aspirin

  • Ibuprofen: 600mg every 8 hours for 1-2 weeks 2, 1
  • Aspirin: 750-1000mg every 8 hours for 1-2 weeks 2, 1
  • Continue until symptoms resolve and CRP normalizes 1
  • Taper by decreasing ibuprofen 200-400mg or aspirin 250-500mg every 1-2 weeks 2
  • Use gastroprotection as needed 1

2. Colchicine (added to NSAIDs/Aspirin)

  • Weight-based dosing:
    • <70kg: 0.5mg once daily
    • ≥70kg: 0.5mg twice daily 2, 1
  • Continue for 3 months for first episode 1
  • Reduces recurrence rates from 15-30% to 8-15% 1, 3
  • Tapering not mandatory but may be considered in the last weeks 2

Second-Line Treatment

Corticosteroids

  • Use only when:
    • NSAIDs/Aspirin contraindicated
    • Failure of first-line therapy
    • Specific indications (autoimmune diseases, pregnancy >20 weeks) 1, 4
  • Dosing: Prednisone 0.2-0.5mg/kg/day 1
  • Caution: Higher risk of recurrence with corticosteroid use, especially at high doses 1, 5
  • When used, should be at low doses with very gradual tapering 5

Activity Restrictions

  • Non-athletes: Restrict physical activity until symptoms resolve and CRP normalizes 2, 1
  • Athletes: Restrict competitive sports for at least 3 months after normalization of symptoms, CRP, ECG, and echocardiogram 2, 1

Follow-up

  • Initial follow-up 1-2 weeks after starting treatment 1
  • Then every 1-2 months until treatment completion 1
  • Monitor:
    • Symptom resolution
    • CRP normalization
    • ECG changes resolution
    • Resolution of pericardial effusion (if present) 1

Special Considerations

Etiology-Specific Treatment

  • Idiopathic/viral: NSAIDs/Aspirin plus colchicine 1
  • Tuberculous: Anti-tuberculosis therapy plus corticosteroids 1, 3
  • Bacterial: Urgent drainage plus targeted antibiotics 1
  • Neoplastic: Treatment of underlying cancer 1
  • Uremic: Treatment of underlying renal failure 1

Common Pitfalls to Avoid

  1. Inadequate NSAID dosing: Full anti-inflammatory doses every 8 hours are required 1
  2. Premature discontinuation: Continue until both symptoms resolve AND CRP normalizes 1
  3. First-line corticosteroid use: Avoid unless specifically indicated 1
  4. Insufficient colchicine duration: Maintain for full recommended period 1
  5. Missing high-risk features: Carefully assess need for hospitalization 2

Most patients with idiopathic/viral pericarditis have a good long-term prognosis when properly treated, with complications like constrictive pericarditis (<0.5%) and tamponade (<3%) being rare in these cases 1, 3.

References

Guideline

Pericarditis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Pericarditis: Rapid Evidence Review.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.